Table 1.
Characteristics of female catheterized patients admitted to a medical service before (PRE) and after (POST) external urinary collection device implementation.
| PRE | POST | ||
|---|---|---|---|
| Characteristic | (n = 259) | (n = 589) | p-value |
| Age, year, median (IQR) | 70 (53, 81) | 73.0 (59, 82) | 0.197 |
| BMI, median (IQR) | 24.7 (21.4, 29.0) | 25.0 (21.3, 30.7) | 0.683 |
| Hospital LOS, days, median (IQR) | 5 (3, 8) | 6 (4, 12) | 0.002 |
| Indwelling catheter days, median (IQR) | 2 (1, 4) | 3 (1, 7) | 0.001 |
| PureWick catheter days, median (IQR) | N/A | 2 (1, 5) | N/A |
| PureWick, n (%) | N/A | 292 (49.6%) | N/A |
| Indwelling urinary catheter, n (%) | 259 (100%) | 397 (67.4%) | <0.001 |
| Medical comorbidities, n (%) | |||
| Diabetes | 94 (36.3%) | 195 (33.1%) | 0.410 |
| CHF | 50 (19.3%) | 128 (21.7%) | 0.479 |
| Current malignancy | 60 (23.2%) | 124 (21.1%) | 0.550 |
| Dementia | 29 (11.2%) | 63 (10.7%) | 0.923 |
| ESRD | 19 (7.3%) | 36 (6.1%) | 0.606 |
| HIV infection | 1 (0.4%) | 2 (0.3%) | 1.000 |
BMI = body mass index, LOS = length of stay, IQR = interquartile range, CHF = congestive heart failure, ESRD = end stage renal disease, HIV = human immunodeficiency virus.